The Effect of TGF-β3 and IL-1β on L-Type Voltage-Operated Calcium Channels and Calcium Ion Homeostasis in Osteoarthritic Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells During Chondrogenesis
<b>Background:</b> Transforming growth factor-β (TGF-β) and interleukin 1β (IL-1β) are key regulators of the chondrogenic differentiation, physiology and pathology of cartilage tissue, with TGF-β promoting chondrogenesis and matrix formation, while IL-1β exerts catabolic effects, inhibiting chondrogenesis and contributing to cartilage degradation. Both cytokines alter the intracellular calcium ion (iCa<sup>2+</sup>) levels; however, the exact pathways are not known. <b>Objectives:</b> This study aimed to evaluate the impact of TGF-β3 and IL-1β on calcium homeostasis in human bone marrow-derived mesenchymal stem cells (hBM-MSCs) and chondrocytes during chondrogenesis. <b>Results:</b> TGF-β3 increased iCa<sup>2+</sup> levels in both hBM-MSCs and chondrocytes. Furthermore, TGF-β3 increased the functional activity of L-type voltage-operated calcium channels (L-VOCCs) in hBM-MSCs but not in chondrocytes. TGF-β3 and IL-1β reduced L-VOCCs subunit CaV1.2 (<i>CACNA1C</i>) gene expression in chondrocytes. In hBM-MSCs, TGF-β3 and IL-1β increased SERCA pump (<i>ATP2A2</i>) gene expression, while in chondrocytes, this effect was observed only with TGF-β3. <b>Conclusions:</b> TGF-β3 increases iCa<sup>2+</sup> both in osteoarthritic chondrocytes and hBM-MSCs during chondrogenesis. In hBM-MSCs, TGF-β3-mediated elevation in iCa<sup>2+</sup> is related to the increased functional activity of L-VOCCs. IL-1β does not change iCa<sup>2+</sup> in osteoarthritic chondrocytes and hBM-MSCs; however, it initiates the mechanisms leading to further downregulation of iCa<sup>2+</sup> in both types of cells. The differential and cell-specific roles of TGF-β3 and IL-1β in the calcium homeostasis of osteoarthritic chondrocytes and hBM-MSCs during chondrogenesis may provide a new insight into future strategies for cartilage repair and osteoarthritis treatment.
Authors
- Ilona Uzielienè (ORCID: https://orcid.org/0000-0001-5484-9163)
- Eiva Bernotienė (ORCID: https://orcid.org/0000-0002-1529-5513)
- Raminta Vaičiulevičiūtė (ORCID: https://orcid.org/0000-0002-4315-7783)
- Алексей Николаевич Шелест
- Aidas Alaburda (ORCID: https://orcid.org/0000-0003-4467-6611)
- Paulina Bialaglovyte (ORCID: https://orcid.org/0009-0001-9491-9514)
Institutions
- Vilnius Gediminas Technical University (LT)
- Vilnius University (LT)
- State Research Institute Centre for Innovative Medicine (LT)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2025-03-07
- DOI
- https://doi.org/10.3390/pharmaceutics17030343
- Citations
- 2
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 3.34